Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

Clinical trial NCT06481228 · RECRUITING

Trial details

NCT number: NCT06481228
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Philadelphia Positive Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia, Adult

Start date: 2024-06-04
Primary completion: 2026-06-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.